Roger J M W Rennenberg
Overview
Explore the profile of Roger J M W Rennenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hilderink J, van der Linden N, Kimenai D, Litjens E, Klinkenberg L, Aref B, et al.
Clin Chem
. 2018 Feb;
64(5):851-860.
PMID: 29483105
Background: Estimated glomerular filtration rate (eGFR) is widely used in clinical practice. This study assessed the within-subject biological variation (CV) of different eGFR equations in people with chronic kidney disease...
12.
Klein D, Rennenberg R, Koopmans R, Prins M
Prev Med Rep
. 2017 Nov;
8:250-255.
PMID: 29181297
Several trigger systems have been developed to screen medical records of hospitalized patients for adverse events (AEs). Because it's too labor-intensive to screen the records of all patients, usually a...
13.
Hilderink J, Rennenberg R, Vanmolkot F, Bekers O, Koopmans R, Meex S
BMJ Open
. 2017 Sep;
7(9):e015854.
PMID: 28864694
Objectives: When monitoring patients over time, clinicians may struggle to distinguish 'real changes' in consecutive blood parameters from so-called natural fluctuations. In practice, they have to do so by relying...
14.
Hilderink J, Klinkenberg L, Aakre K, de Wit N, Henskens Y, van der Linden N, et al.
Clin Chem Lab Med
. 2016 Dec;
55(7):1013-1024.
PMID: 28002028
Background: Middle- and long-term biological variation data for hematological parameters have been reported in the literature. Within-day 24-h variability profiles for hematological parameters are currently lacking. However, comprehensive hour-to-hour variability...
15.
Rennenberg R
Phlebology
. 2016 Feb;
31(1 Suppl):24-7.
PMID: 26916765
Introduction: Venous thromboembolism is a frequently occurring phenomenon with a high risk of acute and chronic complications. To prevent these, subjects are treated with surgical options to restore venous blood...
16.
Vossen L, Schurgers L, van Varik B, Kietselaer B, Vermeer C, Meeder J, et al.
Nutrients
. 2015 Oct;
7(11):8905-15.
PMID: 26516910
Coronary artery calcification (CAC) develops early in the pathogenesis of atherosclerosis and is a strong and independent predictor of cardiovascular disease (CVD). Arterial calcification is caused by an imbalance in...
17.
Rennenberg R
Ned Tijdschr Geneeskd
. 2013 Mar;
157(12):A6044.
PMID: 23515046
Today, hospitals are being confronted with increasing costs for additional safety measures. Not all of these measures are evidence-based; for example, the Dutch practice guidelines on the prevention of contrast-induced...
18.
van Varik B, Rennenberg R, Reutelingsperger C, Kroon A, de Leeuw P, Schurgers L
Front Genet
. 2012 Dec;
3:290.
PMID: 23248645
Vascular disease is still the leading cause of morbidity and mortality in the Western world, and the primary cause of myocardial infarction, stroke, and ischemia. The biology of vascular disease...
19.
Nijssen E, Vermeeren M, Janssen M, Kessels F, van Ommen V, Rennenberg R, et al.
Radiology
. 2012 Nov;
265(3):978-9.
PMID: 23175552
No abstract available.
20.
Weijs B, Blaauw Y, Rennenberg R, Schurgers L, Timmermans C, Pison L, et al.
Eur Heart J
. 2011 Jul;
32(20):2555-62.
PMID: 21775389
Aims: Vitamin K antagonists (VKA) are currently the most frequently used drug to prevent ischaemic stroke in atrial fibrillation (AF) patients. However, VKA use has been associated with increased vascular...